ALSUntangled 56: “ten red flags”-things to be wary of in alternative or off-label products: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration: Vol 21, No 7-8

8,585

Views

CrossRef citations to date

Altmetric

Click to increase image sizeClick to decrease image size

Declaration of interest

ALSUntangled is sponsored by the ALS Association. Richard Bedlack has research support from ALSA and Orion, and consulting support from ALSA, Biogen, Brainstorm Cell, ITF Pharma, Mallinkrodt, New Biotic and Woolsey Pharma.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

ALSUntangled 56: “ten red flags”-things to be wary of in alternative or off-label products

Information for

Open access

Opportunities

Help and information

ALSUntangled 56: “ten red flags”-things to be wary of in alternative or off-label products

Declaration of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature